Jeff L. Ellsworth
Department of Immunology
Zymo-Genetics
Seattle
WA 98102
USA
Name/email consistency: high
- Recombinant soluble human FcgammaR1A (CD64A) reduces inflammation in murine collagen-induced arthritis. Ellsworth, J.L., Hamacher, N., Harder, B., Bannink, K., Bukowski, T.R., Byrnes-Blake, K., Underwood, S., Oliver, C., Waggie, K.S., Noriega, C., Hebb, L., Rixon, M.W., Lewis, K.E. J. Immunol. (2009)
- Targeting immune complex-mediated hypersensitivity with recombinant soluble human FcgammaRIA (CD64A). Ellsworth, J.L., Maurer, M., Harder, B., Hamacher, N., Lantry, M., Lewis, K.B., Rene, S., Byrnes-Blake, K., Underwood, S., Waggie, K.S., Visich, J., Lewis, K.E. J. Immunol. (2008)
- Time window of fibroblast growth factor-18-mediated neuroprotection after occlusion of the middle cerebral artery in rats. Ellsworth, J.L., Garcia, R., Yu, J., Kindy, M.S. J. Cereb. Blood Flow Metab. (2004)
- Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats. Ellsworth, J.L., Garcia, R., Yu, J., Kindy, M.S. Stroke (2003)